| Before weighting | After weighting |
Group S (n = 19) | Group P (n = 38) | Crude OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
Residual blasts | 7 (36.8) | 26 (68.4) | 0.27 (0.085–0.86) | 0.045 | 0.61(0.16–2.3) | 0.47 |
Before weighting | After weighting |
Group S | Group P | P value | Group S | Group P | P value |
Blast count (/μL) | 0 (0–30.0) | 31.5 (0–349) | 0.014 | 1.00 (0–72.0) | 33.4 (0–314) | 0.20 |
- Data are expressed as n (%) or median (25th–75th percentile). Group S patients received general anesthesia with sevoflurane and group P received propofol. Residual blasts: number of patients in whom leukemic blast counts in peripheral blood on day 8 following prednisone chemotherapy were > 0/μL. Blast count: leukemic blast cell count in peripheral blood on day 8 following prednisone chemotherapy
- OR odds ratio, CI confidence interval